Peripheral Nerve Blocks for Amputations
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether nerve blocks with sedation offer safer and better pain control than general anesthesia and opioids for leg amputations. It targets individuals with conditions such as diabetes, high blood pressure, or lung disease, who face higher surgical risks. The trial employs a technique called Peripheral Nerve Block, which numbs specific nerves around the leg to enhance comfort during surgery. Suitable candidates are those requiring an above-the-knee amputation and able to consent to participation. As a Phase 4 trial, this research involves an FDA-approved treatment and aims to understand its benefits for more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude people who use opioids regularly. If you are on opioids, you may need to stop them to participate.
What is the safety track record for these treatments?
Research has shown that peripheral nerve blocks (PNB) are generally safe and effective for patients undergoing above-the-knee amputations. Studies indicate that PNB provides reliable pain relief for high-risk patients, such as those with diabetes, high blood pressure, and heart disease.
One study found that PNB facilitated smoother surgeries and maintained patient stability during procedures. Another study noted that combining PNB with other calming methods reduced the need for strong sedatives, benefiting patients with complex medical histories.
Although information on long-term safety is limited, these findings suggest that PNB offers a promising option for safer and more effective pain control during surgeries like amputations.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about peripheral nerve blocks for amputations because they offer a targeted approach to anesthesia, which can mean less pain and fewer side effects compared to general anesthesia. Unlike traditional methods that affect the whole body, this technique specifically numbs the nerves in the leg with the help of ultrasound guidance. This precision reduces the need for high doses of sedatives, potentially leading to a quicker recovery and fewer complications. Additionally, the use of single-injection nerve blocks could improve pain management during and after surgery, enhancing the overall patient experience.
What evidence suggests that peripheral nerve blocks might be an effective treatment for amputations?
Research shows that peripheral nerve blocks (PNB), which participants in this trial will receive, effectively numb the area during above-knee amputations, especially for high-risk patients. Studies indicate that PNB can control pain and reduce the need for strong sedatives. In these studies, patients remained stable during surgery and experienced less blood loss compared to traditional methods. By using ultrasound to guide the procedure, PNB also manages pain immediately after surgery. Overall, PNB offers a promising option for safer surgeries with better pain control, particularly for patients with conditions like diabetes and heart disease.12367
Who Is on the Research Team?
José R Soberón, MD
Principal Investigator
Malcom Randall VA Medical Center
Are You a Good Fit for This Trial?
This trial is for patients needing above-the-knee amputations who can understand and agree to the study. It's not for those with chronic opioid use, severe liver issues, a BMI over 35, sensorimotor deficits, or true allergies to local anesthetics or sedatives.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive peripheral nerve blocks and intravenous sedatives for above-the-knee amputations
Immediate Post-operative Monitoring
Participants are monitored for pain scores and satisfaction within 48 hours post procedure
Follow-up
Participants are monitored for safety and effectiveness, including 30-day mortality assessment
What Are the Treatments Tested in This Trial?
Interventions
- Intravenous Sedatives
- Lateral Femoral Cutaneous Nerve Blocks
- Obturator Nerve Blocks
- Peripheral Nerve Block
Peripheral Nerve Block is already approved in European Union, United States, Canada, Japan for the following indications:
- Pain control after fracture surgery
- Postoperative pain management
- Chronic pain management
- Pain control after fracture surgery
- Postoperative pain management
- Chronic pain management
- Acute pain management
- Pain control after fracture surgery
- Postoperative pain management
- Chronic pain management
- Pain control after fracture surgery
- Postoperative pain management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
US Department of Veterans Affairs
Collaborator